These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 26670929)

  • 1. Implementing the Xpert® MTB/RIF Diagnostic Test for Tuberculosis and Rifampicin Resistance: Outcomes and Lessons Learned in 18 Countries.
    Ardizzoni E; Fajardo E; Saranchuk P; Casenghi M; Page AL; Varaine F; Kosack CS; Hepple P
    PLoS One; 2015; 10(12):e0144656. PubMed ID: 26670929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Xpert® MTB/RIF assay and microscopy for the diagnosis of Mycobacterium tuberculosis in Namibia.
    Mavenyengwa RT; Shaduka E; Maposa I
    Infect Dis Poverty; 2017 Jan; 6(1):13. PubMed ID: 28086955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of replacing smear microscopy with Xpert MTB/RIF for diagnosing tuberculosis in Brazil: a stepped-wedge cluster-randomized trial.
    Durovni B; Saraceni V; van den Hof S; Trajman A; Cordeiro-Santos M; Cavalcante S; Menezes A; Cobelens F
    PLoS Med; 2014 Dec; 11(12):e1001766. PubMed ID: 25490549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Xpert MTB/RIF assay for diagnosis of tuberculosis and rifampin resistance in county-level laboratories in Hunan province, China.
    Hu P; Bai L; Liu F; Ou X; Zhang Z; Yi S; Chen Z; Gong D; Liu B; Guo J; Tan Y
    Chin Med J (Engl); 2014; 127(21):3744-50. PubMed ID: 25382330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Routine use of Xpert® MTB/RIF in areas with different prevalences of HIV and drug-resistant tuberculosis.
    Page AL; Ardizzoni E; Lassovsky M; Kirubi B; Bichkova D; Pedrotta A; Lastrucci C; de la Tour R; Bonnet M; Varaine F
    Int J Tuberc Lung Dis; 2015 Sep; 19(9):1078-83, i-iii. PubMed ID: 26260829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid molecular tests for tuberculosis and tuberculosis drug resistance: a qualitative evidence synthesis of recipient and provider views.
    Engel N; Ochodo EA; Karanja PW; Schmidt BM; Janssen R; Steingart KR; Oliver S
    Cochrane Database Syst Rev; 2022 Apr; 4(4):CD014877. PubMed ID: 35470432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xpert® MTB/RIF for national tuberculosis programmes in low-income countries: when, where and how?
    Trébucq A; Enarson DA; Chiang CY; Van Deun A; Harries AD; Boillot F; Detjen A; Fujiwara PI; Graham SM; Monedero I; Rusen ID; Rieder HL
    Int J Tuberc Lung Dis; 2011 Dec; 15(12):1567-72. PubMed ID: 22005110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of Xpert MTB/RIF results for the detection of Mycobacterium tuberculosis in clinical samples].
    Ciftçi IH; Aslan MH; Aşık G
    Mikrobiyol Bul; 2011 Jan; 45(1):43-7. PubMed ID: 21341158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case report of a false positive result of the Xpert
    Claessens J; Mathys V; Derdelinckx I; Saegeman V
    Acta Clin Belg; 2017 Jun; 72(3):195-197. PubMed ID: 26400761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic screening for drug-resistant tuberculosis with Xpert(®) MTB/RIF in a referral hospital in Cambodia.
    Lorent N; Kong C; Kim T; Sam S; Thai S; Colebunders R; Rigouts L; Lynen L
    Int J Tuberc Lung Dis; 2015 Dec; 19(12):1528-35. PubMed ID: 26614197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation Research to Inform the Use of Xpert MTB/RIF in Primary Health Care Facilities in High TB and HIV Settings in Resource Constrained Settings.
    Muyoyeta M; Moyo M; Kasese N; Ndhlovu M; Milimo D; Mwanza W; Kapata N; Schaap A; Godfrey Faussett P; Ayles H
    PLoS One; 2015; 10(6):e0126376. PubMed ID: 26030301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is deployement of diagnostic test alone enough? Comprehensive package of interventions to strengthen TB laboratory network: three years of experience in Burkina Faso.
    Alagna R; Combary A; Tagliani E; Sawadogo LT; Saouadogo T; Diandé S; Ouedraogo F; Cirillo DM
    BMC Infect Dis; 2021 Apr; 21(1):346. PubMed ID: 33849486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of Xpert MTB/RIF for routine point-of-care diagnosis of tuberculosis at the primary care level.
    Clouse K; Page-Shipp L; Dansey H; Moatlhodi B; Scott L; Bassett J; Stevens W; Sanne I; Van Rie A
    S Afr Med J; 2012 Sep; 102(10):805-7. PubMed ID: 23034211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scaling-up the Xpert MTB/RIF assay for the detection of tuberculosis and rifampicin resistance in India: An economic analysis.
    Khaparde S; Raizada N; Nair SA; Denkinger C; Sachdeva KS; Paramasivan CN; Salhotra VS; Vassall A; Hoog AV
    PLoS One; 2017; 12(9):e0184270. PubMed ID: 28880875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upfront Xpert MTB/RIF for diagnosis of pediatric TB-Does it work? Experience from India.
    Kalra A; Parija D; Raizada N; Sachdeva KS; Rao R; Swaminathan S; Khanna A; Chopra KK; Hanif M; Singh V; Umadevi KR; Sheladia KN; Rao R; Vasundhara N; S A; A R N; Azeem A; Chhajlani V; Khurana J; Das NJ; Choudhury B; Nair SA; Mall S; Sen R; Chadha SS; Denkinger CM; Boehme C; Sarin S
    PLoS One; 2020; 15(8):e0236057. PubMed ID: 32756559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid molecular test for tuberculosis: impact of its routine use at a referral hospital.
    Casela M; Cerqueira SMA; Casela TO; Pereira MA; Santos SQD; Pozo FAD; Freire SM; Matos ED
    J Bras Pneumol; 2018 Apr; 44(2):112-117. PubMed ID: 29791546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the Xpert MTB/RIF assay for diagnosis of tuberculosis with gastric lavage aspirates in children in sub-Saharan Africa: a prospective descriptive study.
    Bates M; O'Grady J; Maeurer M; Tembo J; Chilukutu L; Chabala C; Kasonde R; Mulota P; Mzyece J; Chomba M; Mukonda L; Mumba M; Kapata N; Rachow A; Clowes P; Hoelscher M; Mwaba P; Zumla A
    Lancet Infect Dis; 2013 Jan; 13(1):36-42. PubMed ID: 23134697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact on Patients' Treatment Outcomes of XpertMTB/RIF Implementation for the Diagnosis of Tuberculosis: Follow-Up of a Stepped-Wedge Randomized Clinical Trial.
    Trajman A; Durovni B; Saraceni V; Menezes A; Cordeiro-Santos M; Cobelens F; Van den Hof S
    PLoS One; 2015; 10(4):e0123252. PubMed ID: 25915745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Xpert MTB/RIF assay on multidrug-resistant tuberculosis treatment outcomes in a health district in South Africa.
    Mahwire TC; Zunza M; Marukutira TC; Naidoo P
    S Afr Med J; 2019 Mar; 109(4):259-263. PubMed ID: 31084692
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.